Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
July 10, 2026Journal of Thrombosis and Thrombolysis

Beyond conventional mechanisms of prosthetic valve thrombosis: immune, genetic, hematologic, hormonal, and hemodynamic perspectives

View Full Paper
Ask AI
Bookmark
Share

Design

Review

Key result

Immune dysregulation, genetic modifiers, transient physiologic states, and localized hemodynamic abnormalities are underrecognized contributors to mechanical prosthetic valve thrombosis.

Authors

MKMacit KalçıkEBEmrah BayamAGAhmet Güner

Discussion

Loading...

Member takes

Overview

May prompt broader PVT evaluation beyond anticoagulation; challenges consensus on conventional drivers and leaves open alternative mechanisms.

Key Points

  • The aim is to explore additional mechanisms contributing to prosthetic valve thrombosis beyond conventional factors.
  • Synthesis of current evidence on immune, genetic, hematologic, hormonal, and hemodynamic factors in prosthetic valve thrombosis.
  • Review of underrecognized contributors such as antiphospholipid antibodies and protein Z–related pathways.
  • Identified immune dysregulation factors can amplify thrombus formation despite adequate anticoagulation.
  • Highlighted the role of genetic modifiers in influencing thrombotic risks, including prothrombotic gene polymorphisms.
  • Emphasized the importance of localized hemodynamic disturbances during thrombus formation in patients with mechanical prosthetic valves.

Structured PICO

P
Population
Patients with mechanical prosthetic valve thrombosis (PVT)

This review highlights the limitations of an anticoagulation-centered paradigm for mechanical prosthetic valve thrombosis and supports a more individualized, mechanism-oriented approach to diagnosis and prevention.

Cite This Study

Kalçık et al. (2026) conducted a review in Mechanical prosthetic valve thrombosis (PVT). Non-conventional mechanisms (immune, genetic, hematologic, hormonal, hemodynamic) was evaluated. Immune dysregulation, genetic modifiers, transient physiologic states, and localized hemodynamic abnormalities are underrecognized contributors to mechanical prosthetic valve thrombosis.

synapsesocial.com/papers/6a50907a6eeac72a437a1870https://doi.org/10.1007/s11239-026-03351-y
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Prosthetic valve thrombosis: contemporary concepts in diagnosis and management2026
  2. 2Treatment of Prosthetic Valve Thrombosis: Current Evidence and Future Directions2015 · 40 citations
  3. 3The Complex Management of Mechanical Prosthetic Valve Thrombosis2023 · 3 citations
  4. 4A global perspective on mechanical prosthetic heart valve thrombosis: Diagnostic and therapeutic challenges2016 · 62 citations
  5. 5Symptomatic mechanical heart valve thrombosis: High morbidity and mortality despite successful treatment options2001 · 20 citations